Zevra Therapeutics (1GDA) Revenue

1 Followers

Zevra Therapeutics Revenue

Zevra Therapeutics had a revenue of 39.66M in the quarter ending Jun 30, 2026, with 9.51%. This bring the company's revenue in the last twelve months to 136.07M, Decreased 11.27%. In the fiscal year ending Dec 31, 2025, Zevra Therapeutics had annual revenue of 106.47M with 350.91% growth.

Revenue (ttm)

136.07M

Revenue Growth

105.19%

P/S Ratio

5.78

Revenue/Employee

€1,745,410

Employees

Market Cap

€615.53M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	106.47M	82.86M	+350.91%
Dec 31, 2024	23.61M	-3.85M	-14.02%
Dec 31, 2023	27.46M	17.30M	+170.26%
Dec 31, 2022	10.16M	-18.49M	-64.53%
Dec 31, 2021	28.65M	15.36M	+115.61%
Dec 31, 2020	13.29M	449.00K	+3.50%
Dec 31, 2019	12.84M	―	+∞%
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―